Revance Therapeutics shares owned by BlackRock
Quarter-by-quarter ownership of Revance Therapeutics shares owned by BlackRock
from 13F filings
Historical chart of BlackRock investment in Revance Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Revance Therapeutics held by BlackRock consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Revance Therapeutics by BlackRock
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2024-06-30 | $1.6M | 2.4M | 0.66 |
| 2024-03-31 | $1.8M | 2.5M | 0.73 |
| 2023-09-30 | $1.6M | 2.0M | 0.80 |
| 2023-06-30 | $1.7M | 1.6M | 1.05 |
| 2023-03-31 | $2.2M | 1.8M | 1.23 |
| 2022-12-31 | $2.6M | 2.9M | 0.91 |
| 2022-06-30 | $2.6M | 3.2M | 0.81 |
| 2021-06-30 | $1.9M | 1.6M | 1.17 |
| 2021-03-31 | $1.8M | 1.6M | 1.12 |